August 6, 2014 / 6:36 AM / in 3 years

BRIEF-Boehringer Ingelheim returns OX-MPI project to Orexo

Aug 6 (Reuters) - Orexo : * Ox-mpi project returned to Orexo * Boehringer Ingelheim has decided to return the OX-MPI project to Orexo. The project aims to develop products based on specific inhibition of prostaglandin E2 (PGE2) in different disease conditions * Orexo is evaluating the results from Boehringer Ingelheim and when this is completed will make a final decision on the potential to continue the project with a new external partner * The return of ox-mpi from boehringer ingelheim has no direct impact on the

financial position of Orexo * The OX-MPI project is associated with an intangible fixed asset of MSEK 62 from the acquisition of Biolipox and this asset will be impaired if a final decision is taken to discontinue the project. Link to press release: here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below